Prague: Medical cannabis market shows growing pains

Warning message

The subscription service is currently unavailable. Please try again later.

The Czech Republic took a bold step back in 2013 when lawmakers agreed to legalise the sale of medicinal cannabis or marihuana. But the development of this market, which can conceivably challenge that of the established pharmaceutical companies across a wide range of pain killers and treatments, is showing some local and global growing pains.

One of those seeking to develop the market for medical cannabis in the Czech Republic and Europe is Prague-based Sean Carney, actually a former business journalist. He is now working as the director of business development and government for Europe for the Canadian cannabis company Tilray. It has a license to produce, process, and manufacture medicinal cannabis products from the Canadian federal government. 

Tilray is seeking to get in there at the start and take off when the European market moves into overdrive. 

I asked Sean how that market is now shaping up. 

“The medical...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.